18: Dr. Meesha Dogan ,CEO, and Dr. Rob Philiber of Cardio Diagnostics Discuss their New Diagnostic Technology

April 3, 2018

Podcast: Play in new window | Download (Duration: 51:58 — 26.9MB) | Embed

Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Blubrry | Podcast Index | Email | TuneIn | RSS | More

Meesha and Robert talk about their companies, what it takes to be a good CEO, what they are working on, and the advances in research technology. There is a lot here to love and to enjoy, and this is one of the few in-person interviews that I’ve done. The audio quality is a little difficult because of that, but there is a lot of great content in here to make up for it! 🙂

Their website.

 

Hyperlinked time stamp show notes (Only on website);

  1. [ 01:30 ] Robert: How they got where they were (i.e. education and motivation).
  2. [ 02:50 ] Epigenetics explained simply.
  3. [ 05:00 ] Meesha: How she got where she is now, where her interest, and passion originated from.
  4. [ 08:10 ] Robert answers how starting a biotech startup has changed over the years.
  5. [ 09:10 ] Meesha answers what the ecosystem is like now.
  6. [ 11:30 ] What is Meesha doing to be a great CEO and how Robert has been a lot of help.
  7. [ 13:35 ] What are the big challenges Meesha has been working on in developing a medical diagnostic test.
  8. [ 15:55 ] How to find great partnerships and what characteristics to look for to ensure your startup has the best possible footing.
  9. [ 17:20 ] Examples of large partnerships that they have developed and/or are developing.
  10. [ 20:20 ] How they would build a CEO out of traits/experiences they would build it from.
  11. [ 27:20 ] How for in advance are they planning.
  12. [ 32:50 ] How big of a difference is their tech going to make compared to other things on the market.
  13. [ 34:00 ] How grants have helped them and their thoughts about how to use them affectively.
  14. [ 35:20 ] What advice would they give to people just starting out.
  15. [ 40:00 ] How have things changed over the past year of their company.
  16. [ 42:50 ] How are they inspired by and how they use it to push themselves.

The description below is taken directly from their website. Why reinvent the wheel, right? 🙂

——————————————————————————————————————-

Dr. Meesha Dogan is a data scientist for Behavioral Diagnostics. She received her PhD in Biomedical Engineering from the University of Iowa. Her expertise bridges medicine and engineering by applying computational techniques on high-throughput biomedical data. Dr. Dogan has co-authored numerous peer-reviewed publications and has applied her data science skills in both academia and industry.

Dr. Dogan is the co-founder and CEO of Cardio Diagnostics, a subsidiary of Behavioral Diagnostics, where she co-invented diagnostic technologies for cardiovascular disease.  Cardio Diagnostics is a pioneer in integrated genetic and epigenetic based tests for precision medicine diagnosis, risk assessment, and treatment of cardiovascular  disorders. When coupled with artificial intelligence via corporate partners, Cardio Diagnostics will allow primary care practitioners to offer state-of-the-art clinical care by determining each individual’s unique environmental and genetic risk for the top 10 leading causes of death, including coronary heart disease.

Dr. Dogan is also an adjunct assistant professor of Biomedical Engineering at the University of Iowa, where she continues her research efforts to transform medicine towards the precision medicine paradigm.

 

Dr. Rob Philibert is the Chief Executive Officer and the principal founder of Behavioral Diagnostics. Dr. Philibert completed his M.D. and PhD through the University of Iowa Medical Scientist Training Program in 1989.  After finishing his residency in Psychiatry in 1993, he then completed a Pharmacology Research Associate Training Program fellowship and spent nearly 6 focused years of bench top research at the National Institutes of Health in Bethesda, Maryland. Subsequently, he returned to the University of Iowa where he is now a Professor of Psychiatry with adjunct appointments in Genetics, Neuroscience, and Biomedical Engineering.

Dr. Philibert is an accomplished scientist and board certified physician who has an extensive portfolio of grant funding, publications, and intellectual property. He and his longtime colleague, Dr. Anup Madan, are the co-inventors of the critical technologies licensed by Behavioral Diagnostics.

Comments are closed.

Categories